| Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in severe patients with COVID-19 S Sciascia, F Aprà, A Baffa, S Baldovino, D Boaro, R Boero, S Bonora, ... Clin Exp Rheumatol 38 (3), 529-532, 2020 | 379 | 2020 |
| Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis D Roccatello, S Baldovino, D Rossi, M Mansouri, C Naretto, M Gennaro, ... Nephrology Dialysis Transplantation 19 (12), 3054-3061, 2004 | 287 | 2004 |
| Rare diseases in Europe: from a wide to a local perspective MD Simone Baldovino, MD Domenica Taruscio, MD Dario Roccatello Isr Med Assoc J 18, 359-63, 2016 | 119 | 2016 |
| Rituximab as a therapeutic tool in severe mixed cryoglobulinemia D Roccatello, S Baldovino, D Rossi, O Giachino, M Mansouri, C Naretto, ... Clinical reviews in allergy & immunology 34, 111-117, 2008 | 99 | 2008 |
| Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further … D Roccatello, S Sciascia, D Rossi, M Alpa, C Naretto, S Baldovino, ... Nephrology Dialysis Transplantation 26 (12), 3987-3992, 2011 | 89 | 2011 |
| The human 26S proteasome is a target of antiretroviral agents M Piccinini, MT Rinaudo, N Chiapello, E Ricotti, S Baldovino, M Mostert, ... Aids 16 (5), 693-700, 2002 | 89 | 2002 |
| Common variable immunodeficiency: crossroads between infections, inflammation and autoimmunity S Baldovino, D Montin, S Martino, S Sciascia, E Menegatti, D Roccatello Autoimmunity reviews 12 (8), 796-801, 2013 | 84 | 2013 |
| Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria S Sciascia, ML Bertolaccini, S Baldovino, D Roccatello, MA Khamashta, ... Autoimmunity reviews 12 (3), 426-429, 2013 | 81 | 2013 |
| Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement D Roccatello, S Baldovino, M Alpa, D Rossi, F Napoli, C Naretto, ... Clinical & Experimental Rheumatology 26 (3), S67, 2008 | 81 | 2008 |
| New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: a prospective study and a review of the literature D Roccatello, S Sciascia, D Di Simone, L Solfietti, C Naretto, R Fenoglio, ... Autoimmunity reviews 15 (6), 529-538, 2016 | 80 | 2016 |
| A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment—clinical response compared … D Roccatello, S Sciascia, S Baldovino, D Rossi, M Alpa, C Naretto, ... Autoimmunity Reviews 14 (12), 1123-1130, 2015 | 68 | 2015 |
| The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction M Radin, K Schreiber, P Costanzo, I Cecchi, D Roccatello, S Baldovino, ... International journal of cardiology 240, 72-77, 2017 | 67 | 2017 |
| Prevalence and thrombotic risk assessment of anti-β2 glycoprotein I domain I antibodies: a systematic review M Radin, I Cecchi, D Roccatello, PL Meroni, S Sciascia Seminars in thrombosis and hemostasis 44 (05), 466-474, 2018 | 63 | 2018 |
| Rituximab in cryoglobulinemic peripheral neuropathy R Cavallo, D Roccatello, E Menegatti, C Naretto, F Napoli, S Baldovino Journal of neurology 256, 1076-1082, 2009 | 63 | 2009 |
| Interferon-γ-inducible subunits are incorporated in human brain 20S proteasome M Piccinini, M Mostert, S Croce, S Baldovino, M Papotti, MT Rinaudo Journal of neuroimmunology 135 (1-2), 135-140, 2003 | 58 | 2003 |
| The role of nail-videocapillaroscopy in early diagnosis of scleroderma D Rossi, A Russo, E Manna, G Binello, S Baldovino, S Sciascia, ... Autoimmunity reviews 12 (8), 821-825, 2013 | 57 | 2013 |
| Improved (4 plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: a 6-year observational study D Roccatello, S Sciascia, S Baldovino, D Rossi, M Alpa, C Naretto, ... American Journal of Nephrology 43 (4), 251-260, 2016 | 55 | 2016 |
| Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay S Sciascia, S Baldovino, K Schreiber, L Solfietti, M Radin, MJ Cuadrado, ... Clinical and Molecular Allergy 14, 1-9, 2016 | 54 | 2016 |
| The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents D Roccatello, S Sciascia, D Rossi, L Solfietti, R Fenoglio, E Menegatti, ... Oncotarget 8 (25), 41764, 2017 | 52 | 2017 |
| Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: a multicenter study S Sciascia, M Radin, I Cecchi, E Rubini, A Scotta, R Rolla, B Montaruli, ... Frontiers in Immunology 10, 376, 2019 | 49 | 2019 |
Savino SciasciaUniversity of Turin, ItalyVerified email at unito.it
